A4F-26008-82764 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-04
Dose 1 — Pfizer-BioNTech
2022-01-25
Registered in v-safe
2022-01-25
Dose 2 — Pfizer-BioNTech
2022-01-25
Health check-in — day 0, dose 2, dependent
Feeling: Good · Site: Pain · None

Adult check-in
2022-01-26
Survey response — days 1–6 daily, dose 2, dependent
MedDRA: Erythema — Feeling: Fair · Fever · Fatigue or tiredness

Free text: Red cheeks (face)

MedDRA releases: 2024-11 · check-in free text available
2022-01-29
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-01-30
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-02-03
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-02-08
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-02-15
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-02-22
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-03
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-08
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-04-26
Survey response — 3 months, dose 2, dependent
MedDRA: Pre-existing disease — Feeling: Good

Free text: Seasonal allergies

MedDRA releases: 2024-11 · check-in free text available
2022-07-28
Survey response — 6 months, dose 2, dependent
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school

Free text: He has had 2 colds

MedDRA releases: 2024-11 · check-in free text available
2023-01-26
Survey response — 12 months, dose 2, dependent
MedDRA: COVID-19, Pharyngitis streptococcal — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-01-26
Report sent to call center — 12 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2023-01-27
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-04	Pfizer-BioNTech	No
2	2022-01-25	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2023-01-26	Unsuccessful

Free text

Release 11 — days 1–6 daily, dose 2, dependent

2022-01-26

Systemic reaction (other): Red cheeks (face)

Release 11 — 3 months, dose 2, dependent

2022-04-26

Symptoms: Seasonal allergies

Release 12 — 6 months, dose 2, dependent

2022-07-28

Symptoms: He has had 2 colds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pharyngitis streptococcal	·	·	✓
SD	Pre-existing disease	·	·	✓
SRO	Erythema	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release